Abstract
Purpose
Hypoxic hepatitis (HH) is a form of hepatic injury following arterial hypoxemia, ischemia, and passive congestion of the liver. We investigated the incidence and the prognostic implications of HH in the medical intensive care unit (ICU).
Methods
A total of 1,066 consecutive ICU admissions at three medical ICUs of a university hospital were included in this prospective cohort study. All patients were screened prospectively for the presence of HH according to established criteria. Independent risk factors of mortality in this cohort of critically ill patients were identified by a multivariate Poisson regression model.
Results
A total of 118 admissions (11%) had HH during their ICU stay. These patients had different baseline characteristics, longer median ICU stay (8 vs. 6 days, p < 0.001), and decreased ICU survival (43 vs. 83%, p < 0.001). The crude mortality rate ratio of admissions with HH was 4.62 (95% CI 3.63–5.86, p < 0.001). Regression analysis demonstrated strong mortality risk for admissions with HH requiring vasopressor therapy (adjusted rate ratio 4.91; 95% CI 2.51–9.60, p < 0.001), whereas HH was not significantly associated with mortality in admissions without vasopressor therapy (adjusted rate ratio 1.79, 95% CI 0.52–6.23, p = 0.359).
Conclusions
Hypoxic hepatitis (HH) occurs frequently in the medical ICU. The presence of HH is a strong risk factor for mortality in the ICU in patients requiring vasopressor therapy.
Similar content being viewed by others
Abbreviations
- ALT:
-
Serum alanine transaminase
- AST:
-
Serum aspartate transaminase
- CI:
-
Confidence interval
- ICU:
-
Intensive care unit
- IQR:
-
Interquartile range
- HH:
-
Hypoxic hepatitis
- RR:
-
Rate ratio
- SAPS:
-
Simplified acute physiology score
References
Fuchs S, Bogomolski-Yahalom V, Paltiel O, Ackerman Z (1998) Ischemic hepatitis. Clinical and laboratory observations of 34 patients. J Clin Gastroenterol 26:183–186
Henrion J, Schapira M, Luwart L, Colin L, Delannoy A, Heller FR (2003) Hypoxic hepatitis: clinical and hemodynamic study in 142 consecutive cases. Medicine 82:392–406
Fuhrmann V, Kneidinger N, Herkner H, Heinz G, Nikfardjam M, Bojic A, Schellongowski P, Angermayr B, Kitzberger R, Warszawska J, Holzinger U, Schenk P, Madl C (2009) Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 35:1397–1405
Thomson SJ, Cowan ML, Johnston I, Musa S, Grounds M, Rahman TM (2009) “Liver function tests” on the intensive care unit: a prospective, observational study. Intensive Care Med 35:1406–1411
Kramer L, Jordan B, Druml W, Bauer P, Metnitz PG, Austrian Epidemiologic Study on Intensive Care, ASDI Study Group (2007) Incidence and prognosis of early hepatic funciton in critically ill patients—a prospective multicenter study. Crit Care Med 35:1099–1104
Birrer R, Takuda Y, Takara T (2007) Hypoxic hepatopathy: pathophysiology and prognosis. Intern Med 46:1063–1070
Ebert E (2006) Hypoxic liver injury. Mayo Clin Proc 81:1232–1236
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841–842
Gibson PR, Dudely F (1984) Ischemic hepatitis: clinical features, diagnosis and prognosis. Aust N Z J Med 14:825–922
Gitlin N, Serio K (1992) Ischemic hepatitis: widening horizons. Am J Gastroenterol 87:831–836
Hickman PE, Potter J (1990) Mortality associated with ischemic hepatitis. Aust N Z J Med 20:32–34
Rawson JS, Achord J (1985) Shock liver. South Med J 78:1421–1425
Seeto RK, Fenn B, Rockey DC (2000) Ischemic hepatitis: clinical presentation and pathogenesis. Am J Med 109:109–113
Whitehead MW, Hawkes ND, Hainsworth I, Kingham JG (1999) A prospective study of the causes of notably raised aspartate aminotransferases of liver origin. Gut 45:129–133
Gillum BS, Graves E, Kozak LJ (1989) Vital and health statistics. Trends in hospital utilization: United States 1965–86. Vital Health Stat 13:1–57
Martin GS, Mannino D, Eaton S, Moss M (2003) The epidemiology of sepsis in the United States from 1979 to 2000. N Engl J Med 348:1546–1554
Waikar SS, Curhan G, Wald R, McCarthy EP, Chertow GM (2006) Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 17:1143–1150
Annane D, Aegerter P, Jars-Guincestre MC, B Guidet for the CUB-Rea Network (2003) Current epidemiology of septic shock. Am J Respir Crit Care Med 168:165–172
Johnson RD, O′Connor C, Kerr M (1995) Extreme serum elevations of aspirate aminotransferase. Am J Gastroenterol 90:1244–1245
Fuhrmann V, Madl C, Mueller C, Holzinger U, Kitzberger R, Funk GC, Schenk P (2006) Hepatopulmonary syndrome in patients wit hypoxic hepatitis. Gastroenterology 131:69–75
Hirsch LJ, Ayabe T, Glick G (1976) Direct effects of various catecholamines on liver circulation in dogs. Am J Physiol 230:1394–1399
Reilly FD, McCuseky R, Cilento EV (1981) Hepatic microvascular regulatory mechanism. I. Adrenergic mechanis. Microvasc Res 21:103–116
Krejci V, Hiltebrand L, Sigurdson GH (2006) Effect of epinephrine, norepinephrine, and phenylepinephrine on microvascular blood flow in the gastrointestinal tract in sepsis. Crit Care Med 34:1456–1463
Mehrabi A, Golling M, Kashfi A, Boucsein T, Schemmer P, Gutt CN, Schmidt J, Büchler MW, Kraus TW (2005) Negative impact of systemic catecholamine administration on hepatic blood perfusion after porcine liver transplantation. Liver Transpl 11:174–187
Aninat C, Seguin P, Descheemaeker PN, Morel F, Malledant Y, Guillouzo A (2008) Catecholamines induce an inflammatory response in human hepatocytes. Crit Care Med 36:848–854
Fuhrmann V, Jäger B, Zubkova A, Drolz A (2010) Hypoxic hepatitis-epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 122:129–139
Nielsen VG, Tan S, Baird MS, Samuelson PN, McCammon AT, Parks DA (1997) Xanthine oxidase mediates myocardial injury after hepatoenteric ischemia–reperfusion. Crit Care Med 25:1044–1050
Peralta C, Perales JC, Bartrons R, Mitchell C, Gilgenkrantz H, Xaus C, Prats N, Fernández L, Gelpí E, Panés J, Roselló-Catafau J (2002) The combination of ischemic preconditioning and liver Bcl-2 over expression is a suitable strategy to prevent liver and lung damage after hepatic ischemia–reperfusion. Am J Pathol 160:2111–2122
Jiang H, Meng F, Li W, Tong L, Qiao H, Sun X (2007) Splenectomy ameliorates acute multiple organ damage induced by warm ischemia reperfusion in rats. Surgery 141:32–40
Szabo G, Romics L, Frendl G (2002) Liver in sepsis and systemic inflammatory response syndrome. Clin Liver Dis 6:1045–1066
Antoniades CG, Berry PA, Wendon JA, Vergani D (2008) The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol 49:845–861
Sakka S, von Hout N (2006) Relation between indocyanine green clearance (ICG) plasma disappearance rate and ICG blood clearance in critically ill patients. Intensive Care Med 32:766–769
Sakka S, Reinhart K, Meier-Hellmann A (2002) Prognostic value of the indocyanine green plasma disappearance rate in critically ill patients. Chest 122:1715–1720
Dresing K, Armstrong VW, Leip CL, Streit F, Burchardi H, Stürmer KM, Oellerich M (2007) Real-time assessment of hepatic function is related to clinical outcome in critically ill patients after polytrauma. Clin Biochem 40:1194–2000
Henrion J, Descamps O, Luwaert R, Schapira M, Parfonry A, Heller F (1994) Hypoxic hepatitis in patients with cardiac failure: incidence in a coronary care unit and measurement of hepatic blood flow. J Hepatol 21:696–703
Naschitz JE, Yeshurun D (1987) Compensated cardiogenic shock: a subset with damage limited to liver and kidneys. The possible salutary effect of low-dose dopamine. Cardiology 74:212–218
Guo L, Richardson KS, Tucker LM, Doll MA, Hein DW, Arteel GE (2004) Role of the renin-angiotensin system in hepatic ischemia reperfusion injury in rats. Hepatology 40:583–589
Casillas-Ramirez A, Amine-Zaouali M, Massip-Salcedo M, Padrissa-Altés S, Bintanel-Morcillo M, Ramalho F, Serafín A, Rimola A, Arroyo V, Rodés J, Roselló-Catafau J, Peralta C (2008) Inhibition of angiotenin II action protects steatotic liver against ischemia–reperfusion injury. Crit Care Med 36:1256–1266
Dezfulian C, Raat N, Shiva S, Gladwin MT (2007) Role of anion nitrite in ischemia–reperfusion cytoprotection and therapeutics. Cardiovasc Res 75:327–388
Lang JD Jr, Teng X, Chumley P, Crawford JH, Isbell TS, Chacko BK, Liu Y, Jhala N, Crowe DR, Smith AB, Cross RC, Frenette L, Kelley EE, Wilhite DW, Hall CR, Page GP, Fallon MB, Bynon JS, Eckhoff DE, Patel RP (2007) Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 117:2583–2591
Conflict of interest
The authors of have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was performed at the intensive care units 13H1, 13H3, and 13I2 of the Medical University of Vienna.
Rights and permissions
About this article
Cite this article
Fuhrmann, V., Kneidinger, N., Herkner, H. et al. Impact of hypoxic hepatitis on mortality in the intensive care unit. Intensive Care Med 37, 1302–1310 (2011). https://doi.org/10.1007/s00134-011-2248-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-011-2248-7